Sign Up to like & get
recommendations!
0
Published in 2020 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2020.598702
Abstract: Background: Roflumilast is an option for treating patients with severe COPD and frequent exacerbations despite optimal therapy with inhaled drugs. The present study focused on whether the phosphodiesterase (PDE) 4 inhibitor roflumilast and its active…
read more here.
Keywords:
anti inflammatory;
bronchial explants;
tnf;
roflumilast ... See more keywords